BioCryst Pharmaceuticals Inc (BCRX): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 20,727 US Dollar | 7 | 2 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 255.535.105 | 10,84 | 5,15 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name BioCryst Pharmaceuticals Inc
Mitarbeiter 435
Handelsplatz NASDAQ
Ticker Symbol BCRX
IPO Datum 1994-03-03
Adresse 4505 Emperor Boulevard, Durham, NC, United States, 27703
Webseite https://www.biocryst.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Charles K. Gayer | CEO, President & Director |
| 2 | Mr. Babar Ghias | CFO & Head of Corporate Development |
| 3 | Ms. Alane P. Barnes | Senior VP, Chief Legal Officer & Corporate Secretary |
| 4 | Mr. John Ruesch | Chief Technical Operations Officer |
| 5 | Dr. David W. Jenkins M.A., Ph.D. | Chief Scientific Officer |
| 6 | Nick Wilder | Manager of Investor Relations |
| 7 | Ms. Stephanie Angelini | Chief People Officer & Communications Officer |
| 8 | Dr. William P. Sheridan MBBS | Chief Development Officer |
| 9 | Dr. Yarlagadda S. Babu Ph.D. | Chief Discovery Officer |
| 10 | Ms. Jinky Ang Rosselli | Chief Data Innovation Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 9,35% | 0,20 Mrd. USD |
| 2 | RA Capital Management, LLC | 6,19% | 0,14 Mrd. USD |
| 3 | State Street Corp | 5,94% | 0,13 Mrd. USD |
| 4 | Deerfield Management Co | 5,91% | 0,13 Mrd. USD |
| 5 | Vanguard Capital Management, LLC | 4,45% | 0,10 Mrd. USD |
| 6 | Vanguard Portfolio Management, LLC | 4,36% | 0,10 Mrd. USD |
| 7 | TCG Crossover Management, LLC | 4,31% | 0,09 Mrd. USD |
| 8 | Perceptive Advisors LLC | 4,03% | 0,09 Mrd. USD |
| 9 | Jupiter Topco LLC | 3,73% | 0,08 Mrd. USD |
| 10 | HHG PLC | 3,49% | 0,08 Mrd. USD |
| 11 | Vestal Point Capital LP | 3,25% | 0,07 Mrd. USD |
| 12 | Two Sigma Investments LLC | 2,65% | 0,06 Mrd. USD |
| 13 | Geode Capital Management, LLC | 2,45% | 0,05 Mrd. USD |
| 14 | Aberdeen Group PLC | 2,08% | 0,05 Mrd. USD |
| 15 | UBS Group AG | 1,99% | 0,04 Mrd. USD |
| 16 | Bank of America Corp | 1,88% | 0,04 Mrd. USD |
| 17 | The Goldman Sachs Group Inc | 1,75% | 0,04 Mrd. USD |
| 18 | Frazier Life Sciences Management, L.P. | 1,57% | 0,03 Mrd. USD |
| 19 | Nuveen, LLC | 1,57% | 0,03 Mrd. USD |
| 20 | Nantahala Capital Management, LLC | 1,49% | 0,03 Mrd. USD |